<< Back to Results
A Phase III, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE)
- Principal Investigator(s)
- C. Michael Franklin, M.D. (Sub-Investigator)
- Charles H. Pritchard, M.D. (Sub-Investigator)
- Mark Lopatin, M.D. (Sub-Investigator)
- David J. Chesner, D.O. (Sub-Investigator)
- Marguerite L. McGarvey, M.D. (Sub-Investigator)
- Dennis A. Jerdan, M.D. (Sub-Investigator)
- Elana R. Eisner, M.D.
-
Clinical Trial Categories
- Contact
- Sue Falbo at 215-657-9977
Location
- Rheumatic Disease Associates, Ltd.
